314 related articles for article (PubMed ID: 33659945)
1. Recent advances in the treatment of
Khurana S; Kahl A; Yu K; DuPont AW
Fac Rev; 2020; 9():13. PubMed ID: 33659945
[No Abstract] [Full Text] [Related]
2. The management of
Deac IŞ; Ofrim AM; Fărcaş RA; Grad S; Popa ŞL; Dumitraşcu DL
Med Pharm Rep; 2024 Jan; 97(1):5-11. PubMed ID: 38344334
[No Abstract] [Full Text] [Related]
3. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children.
Kociolek LK; Crews JD; Schwenk HT
Curr Opin Infect Dis; 2021 Oct; 34(5):527-532. PubMed ID: 34232137
[TBL] [Abstract][Full Text] [Related]
4. Management of
Saha S; Khanna S
Therap Adv Gastroenterol; 2019; 12():1756284819847651. PubMed ID: 31105766
[No Abstract] [Full Text] [Related]
5. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
[TBL] [Abstract][Full Text] [Related]
7. Current management of Clostridioides (Clostridium) difficile infection in adults: a summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline.
Ma J; Dubberke E
Pol Arch Intern Med; 2019 Mar; 129(3):189-198. PubMed ID: 30457126
[TBL] [Abstract][Full Text] [Related]
8. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
9. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection.
Luo Y; Lucas AL; Grinspan AM
Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042
[TBL] [Abstract][Full Text] [Related]
10. Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent
Navalkele BD; Chopra T
Biologics; 2018; 12():11-21. PubMed ID: 29403263
[No Abstract] [Full Text] [Related]
11. Controversies in the Prevention and Treatment of
Bainum TB; Reveles KR; Hall RG; Cornell K; Alvarez CA
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838352
[No Abstract] [Full Text] [Related]
12. Evolution of clinical guidelines for antimicrobial management of
Chaar A; Feuerstadt P
Therap Adv Gastroenterol; 2021; 14():17562848211011953. PubMed ID: 33995583
[No Abstract] [Full Text] [Related]
13. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
Piekarska A; Panasiuk A; Stępień PM
Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
[TBL] [Abstract][Full Text] [Related]
14. Does Fecal Microbiota Transplant Have a Role in Treating Recurrent
Vedala K; Sobash P; Shah P; Kamoga GR
Front Public Health; 2021; 9():670941. PubMed ID: 34178927
[No Abstract] [Full Text] [Related]
15. Updates on
Grace E; Chahine EB
Sr Care Pharm; 2019 Jan; 34(1):29-42. PubMed ID: 30821676
[TBL] [Abstract][Full Text] [Related]
16. Economic burden and cost-effectiveness of therapies for
Gupta A; Ananthakrishnan AN
Therap Adv Gastroenterol; 2021; 14():17562848211018654. PubMed ID: 34104214
[No Abstract] [Full Text] [Related]
17. Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.
Kufel WD; Devanathan AS; Marx AH; Weber DJ; Daniels LM
Pharmacotherapy; 2017 Oct; 37(10):1298-1308. PubMed ID: 28730660
[TBL] [Abstract][Full Text] [Related]
18. Updated Management Guidelines for
Gnocchi M; Gagliardi M; Gismondi P; Gaiani F; De' Angelis GL; Esposito S
Pathogens; 2020 Apr; 9(4):. PubMed ID: 32316346
[No Abstract] [Full Text] [Related]
19.
Al Naser Y; AlGashami M; Aljashaami L
Prz Gastroenterol; 2024; 19(1):1-5. PubMed ID: 38571533
[No Abstract] [Full Text] [Related]
20. Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies.
Giacobbe DR; Dettori S; Di Bella S; Vena A; Granata G; Luzzati R; Petrosillo N; Bassetti M
Infect Dis Ther; 2020 Sep; 9(3):481-494. PubMed ID: 32632582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
